Taysha Gene Therapies, Inc. (TSHA)
4.005
-0.06
(-1.35%)
USD |
NASDAQ |
Nov 17, 16:00
4.005
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Total Liabilities (Quarterly) : 78.06M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 78.06M |
| June 30, 2026 | 83.17M |
| March 31, 2026 | 88.41M |
| December 31, 2025 | 236.79M |
| September 30, 2025 | 97.56M |
| June 30, 2025 | 84.60M |
| March 31, 2025 | 83.30M |
| December 31, 2024 | 204.88M |
| September 30, 2024 | 91.42M |
| June 30, 2024 | 91.52M |
| March 31, 2024 | 99.15M |
| December 31, 2023 | 192.06M |
| September 30, 2023 | 244.88M |
| Date | Value |
|---|---|
| June 30, 2023 | 118.66M |
| March 31, 2023 | 116.55M |
| December 31, 2022 | 127.68M |
| September 30, 2022 | 100.34M |
| June 30, 2022 | 109.62M |
| March 31, 2022 | 115.25M |
| December 31, 2021 | 118.57M |
| September 30, 2021 | 100.65M |
| June 30, 2021 | 55.36M |
| March 31, 2021 | 19.96M |
| December 31, 2020 | 7.579M |
| September 30, 2020 | 11.62M |
| June 30, 2020 | 20.09M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Imunon, Inc. | 9.386M |
| Altimmune, Inc. | 52.08M |
| Agenus, Inc. | 357.70M |
| Amgen, Inc. | 81.70B |
| Anika Therapeutics, Inc. | 52.02M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 435.03M |
| Shareholders Equity (Quarterly) | 356.97M |
| Debt to Equity Ratio | 0.1531 |
| Current Ratio | 18.56 |
| Net Debt Paydown Yield | 0.07% |